120 related articles for article (PubMed ID: 12851315)
1. Agouti-related protein: appetite or reward?
Olszewski P; Wickwire K; Wirth MM; Levine AS; Giraudo SQ
Ann N Y Acad Sci; 2003 Jun; 994():187-91. PubMed ID: 12851315
[TBL] [Abstract][Full Text] [Related]
2. Opioid receptor involvement in the effect of AgRP- (83-132) on food intake and food selection.
Hagan MM; Rushing PA; Benoit SC; Woods SC; Seeley RJ
Am J Physiol Regul Integr Comp Physiol; 2001 Mar; 280(3):R814-21. PubMed ID: 11171662
[TBL] [Abstract][Full Text] [Related]
3. Agouti-related protein in the hypothalamic paraventricular nucleus: effect on feeding.
Wirth MM; Giraudo SQ
Peptides; 2000 Sep; 21(9):1369-75. PubMed ID: 11072124
[TBL] [Abstract][Full Text] [Related]
4. Effect of Agouti-related protein delivered to the dorsomedial nucleus of the hypothalamus on intake of a preferred versus a non-preferred diet.
Wirth MM; Giraudo SQ
Brain Res; 2001 Apr; 897(1-2):169-74. PubMed ID: 11282371
[TBL] [Abstract][Full Text] [Related]
5. Effect of Agouti-related protein on development of conditioned taste aversion and oxytocin neuronal activation.
Wirth MM; Olszewski PK; Levine AS; Giraudo SQ
Neuroreport; 2002 Jul; 13(10):1355-8. PubMed ID: 12151802
[TBL] [Abstract][Full Text] [Related]
6. Role of AgRP on Ghrelin-induced feeding in the hypothalamic paraventricular nucleus.
Shrestha YB; Wickwire K; Giraudo SQ
Regul Pept; 2006 Jan; 133(1-3):68-73. PubMed ID: 16226323
[TBL] [Abstract][Full Text] [Related]
7. A role for agouti-related protein in appetite regulation in a species with continuous nutrient delivery.
Wagner CG; McMahon CD; Marks DL; Daniel JA; Steele B; Sartin JL
Neuroendocrinology; 2004; 80(4):210-8. PubMed ID: 15604600
[TBL] [Abstract][Full Text] [Related]
8. Agouti-related protein (AGRP) has a central inhibitory action on the hypothalamic-pituitary-thyroid (HPT) axis; comparisons between the effect of AGRP and neuropeptide Y on energy homeostasis and the HPT axis.
Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Lechan RM
Endocrinology; 2002 Oct; 143(10):3846-53. PubMed ID: 12239096
[TBL] [Abstract][Full Text] [Related]
9. Sustained orexigenic effect of Agouti related protein may be not mediated by the melanocortin 4 receptor.
Kim MS; Rossi M; Abbott CR; AlAhmed SH; Smith DM; Bloom SR
Peptides; 2002 Jun; 23(6):1069-76. PubMed ID: 12126733
[TBL] [Abstract][Full Text] [Related]
10. Effect of Agouti-related protein in regulation of the hypothalamic-pituitary-thyroid axis in the melanocortin 4 receptor knockout mouse.
Fekete C; Marks DL; Sarkar S; Emerson CH; Rand WM; Cone RD; Lechan RM
Endocrinology; 2004 Nov; 145(11):4816-21. PubMed ID: 15256492
[TBL] [Abstract][Full Text] [Related]
11. 11 beta-hydroxysteroid dehydrogenase type 1 induction in the arcuate nucleus by high-fat feeding: A novel constraint to hyperphagia?
Densmore VS; Morton NM; Mullins JJ; Seckl JR
Endocrinology; 2006 Sep; 147(9):4486-95. PubMed ID: 16763061
[TBL] [Abstract][Full Text] [Related]
12. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein.
Chen HY; Trumbauer ME; Chen AS; Weingarth DT; Adams JR; Frazier EG; Shen Z; Marsh DJ; Feighner SD; Guan XM; Ye Z; Nargund RP; Smith RG; Van der Ploeg LH; Howard AD; MacNeil DJ; Qian S
Endocrinology; 2004 Jun; 145(6):2607-12. PubMed ID: 14962995
[TBL] [Abstract][Full Text] [Related]
13. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats.
Kamegai J; Tamura H; Shimizu T; Ishii S; Sugihara H; Wakabayashi I
Diabetes; 2001 Nov; 50(11):2438-43. PubMed ID: 11679419
[TBL] [Abstract][Full Text] [Related]
14. Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats.
Havel PJ; Hahn TM; Sindelar DK; Baskin DG; Dallman MF; Weigle DS; Schwartz MW
Diabetes; 2000 Feb; 49(2):244-52. PubMed ID: 10868941
[TBL] [Abstract][Full Text] [Related]
15. Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockade.
Hagan MM; Rushing PA; Pritchard LM; Schwartz MW; Strack AM; Van Der Ploeg LH; Woods SC; Seeley RJ
Am J Physiol Regul Integr Comp Physiol; 2000 Jul; 279(1):R47-52. PubMed ID: 10896863
[TBL] [Abstract][Full Text] [Related]
16. Diurnal changes in hypothalamic neuropeptide and SOCS-3 expression: effects of lactation and relationship with serum leptin and food intake.
Denis RG; Bing C; Brocklehurst S; Harrold JA; Vernon RG; Williams G
J Endocrinol; 2004 Oct; 183(1):173-81. PubMed ID: 15525585
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of agouti-related protein and its colocalization with neuropeptide Y in the arcuate nucleus of the hypothalamus during lactation.
Chen P; Li C; Haskell-Luevano C; Cone RD; Smith MS
Endocrinology; 1999 Jun; 140(6):2645-50. PubMed ID: 10342854
[TBL] [Abstract][Full Text] [Related]
18. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo.
Rossi M; Kim MS; Morgan DG; Small CJ; Edwards CM; Sunter D; Abusnana S; Goldstone AP; Russell SH; Stanley SA; Smith DM; Yagaloff K; Ghatei MA; Bloom SR
Endocrinology; 1998 Oct; 139(10):4428-31. PubMed ID: 9751529
[TBL] [Abstract][Full Text] [Related]
19. The melanocortin antagonist AgRP (83-132) increases appetitive responding for a fat, but not a carbohydrate, reinforcer.
Tracy AL; Clegg DJ; Johnson JD; Davidson TL; Benoit SC
Pharmacol Biochem Behav; 2008 May; 89(3):263-71. PubMed ID: 18234306
[TBL] [Abstract][Full Text] [Related]
20. Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues.
Marsh DJ; Miura GI; Yagaloff KA; Schwartz MW; Barsh GS; Palmiter RD
Brain Res; 1999 Nov; 848(1-2):66-77. PubMed ID: 10612698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
